[Ip-health] Opinion Piece - India's new pharma FDI policy undermines competition and paves the way for for multinational pharma corporations to take over Indian generic companies

leena menghaney leenamenghaney at gmail.com
Fri Jul 1 06:09:08 PDT 2016

The Union government’s decision to allow up to 74% foreign direct
investment in pharmaceutical companies through the automatic route could
threaten competition in the pharmaceutical sector and India’s role as a
supplier of low cost, life-saving drugs across the developing world.


Published in Scroll.in

Leena Menghaney
Mobile: 9811365412

More information about the Ip-health mailing list